What specific molecular targets are detected by the NGS hybrid capture platform, how is actionability determined, and what are the translational implications of molecular drivers?

What specific molecular targets are detected by the NGS hybrid capture platform, how is actionability determined, and what are the translational implications of molecular drivers?

What specific molecular targets are detected by the NGS hybrid capture platform, how is actionability determined, and what are the translational implications of molecular drivers across the cancer spectrum?


Created by

CMEducation Resources IQ&A Interactive Intelligence Zone

Presenter

Janice Tsang, MBBS, MRCP(UK), FRCP (Lond.)

Janice Tsang, MBBS, MRCP(UK), FRCP (Lond.)

Specialist in Medical Oncology
Hon. Clinical Assistant Professor
Li Ka Sing Faculty of Medicine
The University of Hong Kong